The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration.
about
Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueOligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microgliaEvidence of inflammatory system involvement in Parkinson's disease.Toll-like receptor 3 is required for development of retinopathy caused by impaired all-trans-retinal clearance in mice.Poly(I:C) promotes TNFα/TNFR1-dependent oligodendrocyte death in mixed glial cultures.A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).Immune aging, dysmetabolism, and inflammation in neurological diseases.Aspects of innate immunity and Parkinson's disease.An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative DiseasesSustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult micePoly(I:C) increases the expression of mPGES-1 and COX-2 in rat primary microgliaToll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia.Toll-like receptor 3 expression in glia and neurons alters in response to white matter injury in preterm infants.Animal Models of Maternal Immune Activation in Depression Research.The neuroimmune basis of fatigueViral and inflammatory triggers of neurodegenerative diseases.Vitamin D and Parkinson's disease.Regulation of microglia activation and deactivation by nuclear receptors.The role of inflammation in sporadic and familial Parkinson's disease.Commentary: Maternal immune activation evoked by polyinosinic: polycytidylic acid does not evoke microglial cell activation in the embryo.Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats.Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.Regulation of Toll-like receptors in the choroid plexus in the immature brain after systemic inflammatory stimuli.Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.Viral-toxin interactions and Parkinson's disease: poly I:C priming enhanced the neurodegenerative effects of paraquat.Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation.Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons.NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease
P2860
Q26852041-D781C809-47CB-43E0-A983-73A74A3B66B4Q30405077-13EA1D31-4FA5-4C6A-8A77-795F36F3EA54Q33874305-14061F67-30EB-4634-AA77-7E49BBF19C35Q33890818-A6F7A9BE-7E05-4C40-8EE6-E14768069104Q34869077-6C2CAB17-FCCB-4F53-B09F-33C2A5105319Q35184144-BD8753AE-98E4-4BE0-B572-364EC03CB09CQ35224798-793B2AD9-C1C4-44FE-98B1-F9AAD63047E6Q35677347-43E5A889-1E46-48C6-8C95-8880FF6F7278Q35813131-4AF6BB04-0C5E-455B-95DF-C96CED97162EQ35843631-99F93261-CDD2-4B50-93D1-37B456216BB5Q35982198-F28CBF7E-DA39-4AAF-89B2-B98F93CC95B0Q36241433-3ED85534-EA84-482C-A17D-3B4A61CBEB4CQ36476232-9F9C53CC-B1DA-45E9-88B7-26A16171E92EQ37020230-AFCD4A4E-9CBD-4E50-BE78-673AC0B90A90Q37303966-968F8F98-36D1-4A9C-8A21-289B3BD7EF2EQ37310541-40FE1B31-D382-456F-B330-D67871C0FCE2Q37470201-E0A6462F-7CA3-4644-B4C7-313D62406311Q37985635-2018A299-E772-4CF4-A0F0-A9E35FA694F2Q38038831-63BCB451-5A4C-4283-9681-329C98534478Q38044319-DBB72F16-3363-4EDF-B0D3-A50DB187A069Q38105903-53089FD6-3BB3-4E6F-BD1E-BC1F08A4E86FQ38592978-5E5146A1-31AA-4B49-BDC5-0D4A2B926887Q38935503-92A3D8EF-1035-43F3-BC16-C8FEA40F6FC8Q38988911-2F4682C7-8EFE-4DF6-9AB4-F418CB1C8ACFQ39392775-F300322A-D7D1-49AC-863D-ADF61F8C1E88Q41072635-D1445C16-4746-4B17-AF0C-DECC81BF4F06Q41597801-A228B54F-57C3-4424-A504-08CB45E07594Q42127205-F5577691-9531-4DB2-B5FF-5335687474B1Q42273974-31CDD3D3-A7D3-4F6E-8E23-9B139DDD2519Q48565252-5D3BD8F8-CB97-4A82-B347-ECF9F4F8EBC9Q51767077-4A4F41C2-849F-4431-9E1F-5220165D2A09Q55399332-083C8388-6C19-43EC-A77C-AD760857C97BQ58695107-0E045879-0A29-4AC8-B2CD-3D5FA4004670
P2860
The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@ast
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@en
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@nl
type
label
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@ast
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@en
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@nl
prefLabel
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@ast
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@en
The Toll-like receptor-3 agoni ...... tal dopaminergic degeneration.
@nl
P2093
P2860
P1476
The Toll-like receptor-3 agoni ...... atal dopaminergic degeneration
@en
P2093
Chee-Yeun Chung
James B Koprich
Michela Deleidi
P2860
P304
16091-16101
P356
10.1523/JNEUROSCI.2400-10.2010
P407
P577
2010-12-01T00:00:00Z